Clinical Trial Update: Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a circular RNA treatment for radiation-induced xerostomia and hyposalivation is currently recruiting, sponsored by RiboX T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyposalivation
• Radiation-induced Xerostomia

Drugs mentioned

• Circular RNA Treatment

Snippet

Sponsor: RiboX Therapeutics Ltd. | Conditions: Radiation-Induced Xerostomia and Hyposalivation | Phase 1, Phase 2 | Status: RECRUITING